Secondary antibodies, either Alexa dye-labeled (Invitrogen) or horseradish peroxidase-conjugated (GE Healthcare), were used for detection. Corticosteroid ointment (0.05% difluprednate; Mitsubishi Tanabe Pharma) and FK506 ointment (0.1% FK506; Astellas Pharma) were used. Sections for immunostaining were prepared as described 37, 38. All the sections were preincubated in goat (♯00044895; Dako Cytomation) or rabbit (♯T0606; Vector laboratories) preimmune serum. Probing with primary and secondary antibodies was performed as described 37. TSA™ (Tyramide signal amplification) system (NEL702; Perkin Elmer) was used for enhancement of the

immunoreactive signals for CD317 staining. Photographs were taken by using Leica DM IRB microscope (Leica

Microsystems) KU-60019 ic50 attached with DP70 digital camera (Olympus). Images acquired from different fields of a specimen were Enzalutamide clinical trial pieced together by using Adobe Photoshop (Adobe Systems) as necessary. H&E staining was performed on paraffin- or OCT-embedded sections 18, 38. Epidermal thickness of the dorsal skin was determined by averaging the values obtained at 30 independent points of each H&E-stained paraffin section (3 μm thick) prepared from at least three individuals of each group. MPO staining was performed on frozen sections (9 μm thick) as described 39. Cells positively stained in 9-μm-thick sections prepared from at least three individuals of each group were counted in the skin or dermis (250 μm in depth buy MG-132 and 4000 μm in width) or in

the epidermis (1000 μm of the epidermis/dermis border in length). Total cellular RNA isolation, cDNA synthesis, RT-PCR, and qRT-PCR were performed as described 19. Relative mRNA levels of each transcript were determined by the ΔΔCt method with the reference gene, β-actin. The primers used are listed in Supporting Information Table 1. Keratinocytes were isolated from the dorsal skin of newborn mice and cultured as described 18. Absence of leukocyte contamination was confirmed by RT-PCR analysis for the CD68, CD205, CD317, CD207, and CD4 mRNAs (data not shown). Cells were incubated in complete culture media containing 10 μM BrdU for 90 min and immunostained for BrdU. The concentration of IL-23 released from primary-cultured keratinocytes to the culture medium for 48 h was determined by ELISA using Quantikine (M2300; R&D Systems). Approximately 20 μg of anti-mouse IL-23 p19 monoclonal antibody (clone G23-8, 16-7232; eBioscience) and isotype control antibody (clone R3-34, 553921; BD pharmingen) were intradermally injected into the right and left ear auricles, respectively, of three 4-wk-old male K5-PLCε-TG mice at days 0 and 5. At day 8, their specimens were prepared for analysis. Data are expressed as the mean±SD.